Merrimack Pharmaceuticals Inc
MACKDelisted May 10, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001274792
Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Merrimack Pharmaceuticals Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 12 | 2 | −10 |
| Shares | 437.3K | 349 | −437.0K (−99.9%) |
| Value | $5.32M | $0 | −$5.32M (−100.0%) |
New holders (0)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (10)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Dimensional Fund Advisors LP | 318,995 | $4.83M |
| Goldman Sachs Group Inc | 29,807 | $451.0K |
| Rhumbline Advisers | 2,480 | $37.5K |
| JBF Capital, Inc. | 39,637 | $1.19K |
| Marshall Wace, LLP | 38,221 | $1.15K |
| Caldwell Sutter Capital, Inc. | 7,458 | $0 |
| Nisa Investment Advisors, LLC | 15 | $0 |
| CWM, LLC | 22 | $0 |
| Cornerstone Planning Group LLC | 231 | $0 |
| Covestor Ltd | 106 | $0 |